home / stock / lfcr / lfcr news


LFCR News and Press, Lifecore Biomedical Inc. From 11/06/25

Stock Information

Company Name: Lifecore Biomedical Inc.
Stock Symbol: LFCR
Market: NASDAQ

Menu

LFCR LFCR Quote LFCR Short LFCR News LFCR Articles LFCR Message Board
Get LFCR Alerts

News, Short Squeeze, Breakout and More Instantly...

LFCR - Expected US Company Earnings on Thursday, November 6th, 2025

Avidity Biosciences Inc. (RNA) is expected to report $-1.05 for Q3 2025 Universal Electronics Inc. (UEIC) is expected to report $-0.15 for Q3 2025 Intercorp Financial Services Inc. (IFS) is expected to report $1.15 for Q3 2025 Clear Secure Inc. Class A (YOU) is expected to report $0.2...

LFCR - Expected US Company Earnings on Friday, October 31st, 2025

Federal Realty Investment Trust (FRT) is expected to report $1.76 for Q3 2025 Rithm Property Trust Inc. (RPT) is expected to report $0.04 for Q3 2025 Oil States International Inc. (OIS) is expected to report $0.1 for Q3 2025 Charter Communications Inc. (CHTR) is expected to report $9....

LFCR - Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025

CHASKA, Minn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the three months ende...

LFCR - Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product Represents Second Agreement Signed with Same Major Multinational Organization in Recent Months Separate Pre-Clinical Formulation Development Agre...

LFCR - Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

CHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide&#x...

LFCR - Expected US Company Earnings on Friday, October 24th, 2025

Better For You Wellness Inc (BFYW) is expected to report for quarter end 2025-08-31 ENI S.p.A. (E) is expected to report $0.73 for Q3 2025 Hexagon AB ADR (HXGBY) is expected to report $0.1 for Q3 2025 Stellar Bancorp Inc. (STEL) is expected to report $0.5 for Q3 2025 Non-Invasive ...

LFCR - Lifecore Biomedical: Our Fill-Finish CDMO

2025-10-20 22:00:00 ET The following segment was excerpted from the Laughing Water Capital Q3 2025 Letter. ... Read the full article on Seeking Alpha For further details see: Lifecore Biomedical: Our Fill-Finish CDMO

LFCR - Expected US Company Earnings on Friday, October 17th, 2025

Chino Commercial Bancorp (CCBC) is expected to report for Q3 2025 HDFC Bank Limited (HDB) is expected to report $0.36 for Q2 2026 Parke Bancorp Inc. (PKBK) is expected to report for Q3 2025 Truist Financial Corporation (TFC) is expected to report $0.99 for Q3 2025 Comerica Incorpo...

LFCR - Expected US Company Earnings on Friday, October 10th, 2025

Chitogenx Inc Com (CHNXF) is expected to report for quarter end 2025-07-31 Unity Bancorp Inc. (UNTY) is expected to report $1.27 for Q3 2025 Hingham Institution for Savings (HIFS) is expected to report for Q3 2025 GlobeStar Therapeutics Corp (GSTC) is expected to report for quarter en...

LFCR - Rating Downgrade: Lifecore, Ready To Go, But Problems Remain

2025-10-09 04:52:31 ET Lifecore Biomedical ( LFCR ) is a fully integrated contract development and manufacturing organization (CDMO). We covered the shares some 10 months ago, so for an introduction to the company, we refer you to that article. What follows is an update.... ...

Previous 10 Next 10